Company profile: PamGene
1.1 - Company Overview
Company description
- Provider of kinase activity profiling and diagnostic solutions: IOpener diagnostic blood test measuring protein kinase activity to indicate likelihood of response to ICI therapy; PamChip microarray platform, PamStation instrument, and BioNavigator software; contract research for kinase inhibitor discovery and optimization; and ISO13485 compliant IVD assay services performing IOpener for melanoma and lung cancer patients.
Products and services
- Diagnostic Assay Services Facility: An ISO13485-compliant facility by PamGene performing the IOpener test as an IVD assay service for melanoma and lung cancer patients
- IOpener Diagnostic Blood Test: A blood-based diagnostic developed by PamGene for rapid measurement of protein kinase activity in patients’ blood, indicating likelihood of response to ICI therapy
- PamChip Microarray Platform: A microarray-based platform for kinase activity profiling, allowing for the analysis of cellular signaling in various disease areas
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PamGene
HTG Molecular
HQ: United States
Website
- Description: Provider of assays and reagent systems for gene expression analysis, including the HTG Transcriptome Panel for full transcriptome profiling to support drug and companion diagnostic discovery; HTG EpiEdgeSeq for RNA modification profiling; and a Drug Discovery Engine and pipeline targeting RNA‑Modifying Proteins across oncology, autoimmune, neurodegenerative, and rare diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HTG Molecular company profile →
Crescendo Bioscience
HQ: United States
Website
- Description: Provider of quantitative, objective diagnostic tools for rheumatologists, delivering clinical insights to manage patients with autoimmune and inflammatory diseases. Provides diagnostic, prognostic, staging, therapy selection, and monitoring facilities to physicians.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Crescendo Bioscience company profile →
Gateway Genomics
HQ: France
Website
- Description: Provider of genetically based tests for families and cancer care, including SneakPeek Early Gender Test to determine fetal sex from a small maternal blood sample as early as six weeks; Foresight Carrier Screen for inherited conditions; Prequel Prenatal Screen to identify risk of chromosomal conditions like Down syndrome from week 10; and oncology tests Prolaris and Precise to assess prostate cancer aggressiveness and tumor variants to guide treatment decisions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gateway Genomics company profile →
Moleculo
HQ: United States
Website
- Description: Provider of technologies for generating long reads for genome analysis tools, offering a novel DNA sequencing method that delivers long, accurate reads and improves the efficiency and accuracy of many existing DNA sequencing applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Moleculo company profile →
CellforCure
HQ: France
Website
- Description: Provider of advanced therapy medicinal product expertise as a key industrial and innovative player in the field.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CellforCure company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PamGene
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PamGene
2.2 - Growth funds investing in similar companies to PamGene
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PamGene
4.2 - Public trading comparable groups for PamGene
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →